SCHEMBL15328478

SCHEMBL15328478

CCS(=O)(=O)c1cc(Cl)cc(C)c1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
PKM P14618 2/20 0.40
MAPT P10636 1/20 0.40
LMNA P02545 1/20 0.39
USP2 O75604 1/20 0.37
ALDH1A1 P00352 5/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPSR1 Q6W5P4 3/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
EPAS1 Q99814 2/20 0.35
FFAR4 Q5NUL3 1/20 0.34
DDR1 Q08345 3/20 0.34
UPP1 Q16831 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10817520 0.83 KDM4E (0.44) KDM4EPKMMAPTLMNAUSP2
SCHEMBL3958204 0.75 KDM4E (0.52) KDM4EMAPTLMNAUSP2ALDH1A1
SCHEMBL16483020 0.75 KDM4E (0.46) KDM4EMAPTLMNAUSP2ALDH1A1
SCHEMBL15328696 0.70 ALDH1A1 (0.47) KDM4EMAPTLMNAUSP2ALDH1A1
SCHEMBL967389 0.70 KDM4E (0.47) KDM4EMAPTLMNAUSP2ALDH1A1
SCHEMBL25437275 0.70 ALDH1A1 (0.43) KDM4EPKMMAPTALDH1A1MEN1
SCHEMBL18620011 0.69 GAA (0.49) LMNAMEN1KMT2ADDR1HTT
SCHEMBL15328361 0.69 KDM4E (0.41) KDM4EPKMMAPTLMNAUSP2
SCHEMBL15328692 0.68 KDM4E (0.40) KDM4EPKMMAPTLMNAUSP2
SCHEMBL11799620 0.67 KDM4E (0.46) KDM4EMAPTLMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 KDM4E 245/4885PKM 1021/4885MAPT 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.